biotech

CytoAgents

Pittsburgh-based biotech company CytoAgents is launching into phase one of clinical trials this month on a drug designed to treat people with COVID-19 who develop serious respiratory distress when their immune system overreacts to the virus.

University of Pittsburgh

A new biotech incubator specializing in immunology will open in around two years at the site of a former Ford auto plant on Baum Boulevard.